Although further validation in a large cohort is necessary, the potential use of TAGLN as a biomarker for kidney fibrosis has been reported in Chronic Renal Insufficiency Cohort (CRIC) study that used human plasma proteome data. The gene discussed is TAGLN; the disease is chronic kidney disease.